0000899243-21-035722.txt : 20210913 0000899243-21-035722.hdr.sgml : 20210913 20210913182422 ACCESSION NUMBER: 0000899243-21-035722 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210909 FILED AS OF DATE: 20210913 DATE AS OF CHANGE: 20210913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Anthony CENTRAL INDEX KEY: 0001606030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 211250726 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-09 0 0000730272 REPLIGEN CORP RGEN 0001606030 Hunt Anthony C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 1 0 0 Chief Executive Officer Common Stock 2021-09-09 4 M 0 25000 32.40 A 214495 D Common Stock 2021-09-09 4 S 0 8536 294.22 D 205959 D Common Stock 2021-09-09 4 S 0 14825 294.90 D 191134 D Common Stock 2021-09-09 4 S 0 1631 296.09 D 189503 D Common Stock 2021-09-09 4 S 0 8 296.58 D 189495 D Stock Option (Right to Buy) 32.40 2021-09-09 4 M 0 25000 0.00 A 2027-02-23 Common Stock 25000 25154 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. $294.22 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.49 to $294.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $294.90 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.49 to $295.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $296.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.49 to $296.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is currently exercisable. /s/ Kimberly Brown (Attorney in Fact) 2021-09-13